查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1301173

控釋藥物輸送市場規模、份額和趨勢分析報告：2023-2030 年按技術、釋放機制、應用、地區、細分市場劃分的趨勢

Controlled Release Drug Delivery Market Size, Share & Trends Analysis Report, By Technology (Targeted Delivery, Transdermal), By Release Mechanism, By Application, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

控釋給藥市場的增長和趨勢

據Grand View Research, Inc.最新報告顯示，預計到2030年，全球控釋給藥市場規模將達到1101.3億美元，複合年增長率為10.6%。

與控釋藥物輸送系統相關的優勢，例如提高治療效果、減少副作用和降低治療成本，是預測期內推動市場增長的因素。與傳統的交付形式相比，這些技術具有多種優勢。減少劑量和給藥頻率、增強患者依從性、減少胃腸道副作用、療效均一化、提高功效和安全性以及減少血漿藥物濃度的變異性是控釋技術的主要優點和一些優點。

體內存在影響藥物吸收、生物利用度和穩定性的多種生物屏障，為控釋藥物遞送產品開闢了廣闊的前景。例如，控釋藥物遞送系統使得遞送更大且複雜的分子成為可能，例如DNA/RNA、蛋白質和多□。此外，醫療保健專業人員對控釋給藥系統相對於傳統系統的優越性的認識不斷增強，預計從長遠來看也將提振市場需求。

老年人和兒童人口的增加是影響市場增長的主要因素之一。這是因為在這個年齡組中，不提供處方的比例很高。各種藥物輸送系統創新為老年人和兒科人群提供了簡單的解決方案，進一步推動了市場的發展。藥物的控釋可以根據特定時間段內所需的劑量而變化，從而減少老年人群的藥物過量。

控釋藥物輸送市場報告亮點

  • 從應用來看，由於使用量的增加和給藥的便利性，口服控釋系統將在 2022 年佔據最大的市場份額。
  • 靶向藥物遞送由於具有提高治療效果和提高安全性等多種優勢，預計將成為預測期內增長最快的技術領域。
  • 基於激活調節藥物遞送系統的滲透遞送領域預計將出現最高的複合年增長率，因為它不受pH、食物攝入和胃腸道蠕動等各種因素的影響。

目錄

第一章 調查方法和範圍

  • 市場細分和範圍
  • 調查方法
  • 信息採購
  • 信息或數據分析
  • 市場形成和驗證
  • 型號詳情
  • 二級信息列表
  • 主要信息列表
  • 目的

第二章執行摘要

  • 市場展望
  • 分部展望
  • 競爭考慮

3.控釋給藥市場變量、趨勢和範圍

  • 市場譜系展望
    • 母公司市場展望
    • 相關/輔助市場展望
  • 採用和增長前景圖
  • 行業價值鏈分析
    • 贖回框架
  • 市場動態
    • 市場驅動力分析
    • 市場約束因素分析
  • 控釋藥物輸送市場分析工具
    • 行業分析-波特分析
    • PESTEL 分析
    • 主要交易和戰略聯盟分析
    • 市場進入策略

第四章全球控釋給藥市場：技術評估與趨勢分析

  • 定義和範圍
  • 2022 年和 2030 年控釋給藥市場份額
  • 細分儀表板
  • 按技術劃分：全球控釋給藥市場展望
  • 2018-2030年以下市場規模、預測和趨勢分析
    • 厄斯特技術
    • 凝聚
    • 微膠囊化
    • 注入
    • 透皮
    • 定向投放
    • 其他（微機電技術、脂質體）

第五章全球控釋給藥市場：釋放機制估計及趨勢分析

  • 定義和範圍
  • 2022 年和 2030 年控釋給藥市場份額
  • 細分儀表板
  • 按釋放機制：全球控釋給藥市場展望
  • 2018-2030年以下市場規模、預測和趨勢分析
    • 聚合物基系統
    • 微儲庫分區控制給藥系統
    • 反饋調節藥物輸送系統
    • 激活控制的藥物輸送系統
    • 化學活化

第六章全球控釋給藥市場：應用估算和趨勢分析

  • 定義和範圍
  • 2022 年和 2030 年控釋給藥市場份額
  • 細分儀表板
  • 按應用分類：全球控釋給藥市場展望
  • 2018-2030年以下市場規模、預測和趨勢分析
    • 定量吸入器
    • 可注射的
    • 透皮貼劑和眼貼劑
    • 輸液泵
    • 口服控釋給藥系統
    • 藥物洗脫支架

第七章全球控釋給藥市場：區域估計與趨勢分析

  • 2022 年和 2030 年區域市場份額分析
  • 區域市場儀表板
  • 全球區域市場快照
  • 2022 年區域市場份額和主要參與者
  • SWOT 分析，按因素（政治/法律、經濟/技術）
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 2018-2030 年市場規模、預測、數量和趨勢分析：
  • 北美
    • 2018-2030 年市場估計和預測
    • 美國
    • 加拿大
  • 歐洲
    • 2018-2030 年市場估計和預測
    • 英國
    • 德國
    • 法國
    • 意大利
    • 西班牙
    • 俄羅斯
    • 瑞士
    • 荷蘭
    • 瑞典
    • 比利時
    • 其他
  • 亞太地區
    • 2018-2030 年市場估計和預測
    • 日本
    • 中國
    • 印度
    • 韓國
    • 泰國
    • 印度尼西亞
    • 菲律賓
    • 越南
    • 馬來西亞
    • 新加坡
    • 其他
  • 拉丁美洲
    • 2018-2030 年市場估計和預測
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 其他
  • MEA
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 科威特
    • 以色列
    • 其他

第8章 競爭格局

  • 主要市場進入者的最新發展和影響分析
  • 公司/競爭對手分類
  • 供應商情況
  • 上市公司
  • 民營企業
    • 關鍵初創企業/技術顛覆者/創新者名單
    • 資金前景
    • 區域網絡圖
    • 公司市場分析（地理位置、產品組合、主要聯盟、行業經驗）
    • 供應商排名
    • 主要公司概況
    • Depomed, Inc.
    • Coating Place, Inc.
    • Corium International, Inc.
    • Johnson and Johnson Services, Inc.
    • Alkermes plc
    • Pfizer, Inc.
    • Orbis Biosciences, Inc.
    • Capsugel
    • Merck and Co., Inc.
    • Aradigm Corporation
Product Code: GVR-2-68038-347-8

Controlled Release Drug Delivery Market Growth & Trends

The global controlled release drug delivery market size is expected to reach USD 110.13 billion by 2030, registering a CAGR of 10.6% according to a new report by Grand View Research, Inc. The benefits associated with controlled release drug delivery systems such as increased therapeutic efficacy, fewer side effects, and low treatment cost are the factors driving the growth of the market during the forecast period. These technologies offer various benefits over traditional delivery forms. Reduced dosage and dosage frequency, enhanced patient compliance, less gastrointestinal side effects, uniform drug effect, improved drug efficacy and safety, and reduced fluctuation of plasma drug levels are some of the major advantages offered by controlled release technology.

The presence of multiple in-vivo biological barriers that affect the absorption, bioavailability, and stability of the drug has opened a wide horizon for controlled release drug delivery products. For instance, a controlled release drug delivery system has enabled the delivery of even large and complex molecules such as DNA/RNA, proteins, and polypeptides. Additionally, the rising awareness among healthcare professionals, regarding the advantage of controlled release drug delivery systems over conventional systems is expected to drive the demand for the market in long run.

The rapidly increasing geriatric and pediatric population is one of the major factors impacting the growth of the market. Since a major proportion of prescription non-adherence cases is observed in this age group of the population. Innovations in various drug delivery systems have been providing the geriatric and pediatric populations with easy solutions, which are further propelling the market. Controlled release of drugs allows a reduction in overdose in the elderly population as they can be altered according to the required dosage over a specific period of time.

Controlled Release Drug Delivery Market Report Highlights

  • Based on application, oral controlled release systems held the largest share in the market in 2022 owing to increasing usage and ease of convenience offered for the administration of medication
  • Targeted drug delivery is poised to be the fastest-growing technology segment during the forecast period owing to its various benefits such as increased therapeutic efficacy coupled with increased safety
  • The osmotic delivery segment, based on activation modulation drug delivery systems, is likely to witness the highest CAGR due to its ability to not be affected by various factors, such as pH, food consumption, and gastrointestinal motility

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. Release mechanism
    • 1.1.3. Application
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Release mechanism outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. controlled release drug delivery Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Increase in need for controlled release dosage forms for pediatric and geriatric population
      • 3.4.1.2. Increased compliance due to nature of dosage forms
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. Limited amount of controlled release dosage forms is acceptable for usage in pediatric conditions
      • 3.4.2.2. Need for high dose of active pharmaceutical ingredient
  • 3.5. controlled release drug delivery Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Global controlled release drug delivery Market: Technology Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Wurster technique
    • 4.1.2. Coacervation
    • 4.1.3. Micro encapsulation
    • 4.1.4. Implants
    • 4.1.5. Transdermal
    • 4.1.6. Targeted delivery
    • 4.1.7. Others (microelectromechanical technology, liposomes)
  • 4.2. Controlled release drug delivery Market Share, 2022 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global controlled release drug delivery Market by Technology Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Wurster technique
      • 4.5.1.1. Wurster technique controlled release drug delivery market, 2018 - 2030 (USD Million)
    • 4.5.2. Coacervation
      • 4.5.2.1. Coacervation controlled release drug delivery market, 2018 - 2030 (USD Million)
    • 4.5.3. Micro Encapsulation
      • 4.5.3.1. Micro encapsulation controlled release drug delivery market, 2018 - 2030 (USD Million)
    • 4.5.4. Implants
      • 4.5.4.1. Implants controlled release drug delivery market, 2018 - 2030 (USD Million)
    • 4.5.5. Transdermal
      • 4.5.5.1. Transdermal controlled release drug delivery market, 2018 - 2030 (USD Million)
    • 4.5.6. Targeted delivery
      • 4.5.6.1. Targeted delivery controlled release drug delivery market, 2018 - 2030 (USD Million)
    • 4.5.7. Others (microelectromechanical technology, liposomes)
      • 4.5.7.1. Others controlled release drug delivery market, 2018 - 2030 (USD Million)

Chapter 5. Global controlled release drug delivery Market: Release Mechanism Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Polymer Based Systems
    • 5.1.2. Micro Reservoir Partition Controlled Drug Delivery Systems
    • 5.1.3. Feedback Regulated Drug Delivery Systems
    • 5.1.4. Activation-modulated Drug Delivery Systems
      • 5.1.4.1. Osmotic Pressure Activated
      • 5.1.4.2. Hydrodynamic Pressure Activated
      • 5.1.4.3. Vapor Pressure Activated
      • 5.1.4.4. Mechanically Activated
      • 5.1.4.5. Magnetically Activated
    • 5.1.5. Chemically Activated
      • 5.1.5.1. pH Activated
      • 5.1.5.2. Hydrolysis Activated
      • 5.1.5.3. Enzyme Activated
  • 5.2. Controlled release drug delivery Market Share, 2022 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global controlled release drug delivery Market by Release Mechanism Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Polymer based systems
      • 5.5.1.1. Polymer based systems controlled release drug delivery market, 2018 - 2030 (USD Million)
    • 5.5.2. Micro reservoir partition controlled drug delivery systems
      • 5.5.2.1. Micro reservoir partition controlled drug delivery systems market, 2018 - 2030 (USD Million)
    • 5.5.3. Feedback regulated drug delivery systems
      • 5.5.3.1. Feedback regulated drug delivery systems market, 2018 - 2030 (USD Million)
    • 5.5.4. Activation-modulated drug delivery systems
      • 5.5.4.1. Activation-modulated drug delivery systems market, 2018 - 2030 (USD Million)
      • 5.5.4.2. Osmotic pressure activated systems market, 2018 - 2030 (USD Million)
      • 5.5.4.3. Hydrodynamic pressure activated systems market, 2018 - 2030 (USD Million)
      • 5.5.4.4. Vapor pressure activated systems market, 2018 - 2030 (USD Million)
      • 5.5.4.5. Mechanically activated systems market, 2018 - 2030 (USD Million)
      • 5.5.4.6. Magnetically activated systems market, 2018 - 2030 (USD Million)
    • 5.5.5. Chemically activated
      • 5.5.5.1. pH activated controlled release drug delivery market, 2018 - 2030 (USD Million)
      • 5.5.5.2. Hydrolysis activated controlled release drug delivery market, 2018 - 2030 (USD Million)
      • 5.5.5.3. Enzyme activated controlled release drug delivery market, 2018 - 2030 (USD Million)

Chapter 6. Global controlled release drug delivery Market: Application Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Metered Dose Inhalers
    • 6.1.2. Injectable
    • 6.1.3. Transdermal and Ocular Patches
    • 6.1.4. Infusion Pumps
    • 6.1.5. Oral Controlled-drug delivery Systems
    • 6.1.6. Drug Eluting Stents
  • 6.2. controlled release drug delivery Market Share, 2022 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global controlled release drug delivery Market by Application Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Metered dose inhalers
      • 6.5.1.1. Metered dose inhaler controlled release drug delivery market, 2018 - 2030 (USD Million)
    • 6.5.2. Injectable
      • 6.5.2.1. Injectable controlled release drug delivery market, 2018 - 2030 (USD Million)
    • 6.5.3. Transdermal and ocular patches
      • 6.5.3.1. Transdermal and ocular patches controlled release drug delivery market, 2018 - 2030 (USD Million)
    • 6.5.4. Infusion Pumps
      • 6.5.4.1. Infusion pumps controlled release drug delivery market, 2018 - 2030 (USD Million)
    • 6.5.5. Oral controlled release drug delivery system
      • 6.5.5.1. Oral controlled release drug delivery market, 2018 - 2030 (USD Million)
    • 6.5.6. Drug eluting stents
      • 6.5.6.1. Drug eluting stents controlled release drug delivery market, 2018 - 2030 (USD Million)

Chapter 7. Global controlled release drug delivery Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2022 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Regional Market Share and Leading Players, 2022
    • 7.4.1. North America
    • 7.4.2. Europe
    • 7.4.3. Asia Pacific
    • 7.4.4. Latin America
    • 7.4.5. Middle East and Africa
  • 7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 7.5.1. North America
    • 7.5.2. Europe
    • 7.5.3. Asia Pacific
    • 7.5.4. Latin America
    • 7.5.5. Middle East and Africa
  • 7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
  • 7.7. North America
    • 7.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.2. U.S.
      • 7.7.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.3. Canada
      • 7.7.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8. Europe
    • 7.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.2. UK
      • 7.8.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.3. Germany
      • 7.8.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.4. France
      • 7.8.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.5. Italy
      • 7.8.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.6. Spain
      • 7.8.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.7. Russia
      • 7.8.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.8. Switzerland
      • 7.8.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.9. The Netherland
      • 7.8.9.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.10. Sweden
      • 7.8.10.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.11. Belgium
      • 7.8.11.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.12. Others
      • 7.8.12.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9. Asia Pacific
    • 7.9.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.2. Japan
      • 7.9.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.3. China
      • 7.9.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.4. India
      • 7.9.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.5. South Korea
      • 7.9.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.6. Thailand
      • 7.9.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.7. Indonesia
      • 7.9.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.8. Philippines
      • 7.9.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.9. Vietnam
      • 7.9.9.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.10. Malaysia
      • 7.9.10.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.11. Singapore
      • 7.9.11.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.12. Others
      • 7.9.12.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.10. Latin America
    • 7.10.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.10.2. Brazil
      • 7.10.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.10.3. Mexico
      • 7.10.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.10.4. Argentina
      • 7.10.4.7. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.10.5. Colombia
      • 7.10.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.10.6. Chile
      • 7.10.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.10.7. Others
      • 7.10.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.11. MEA
    • 7.11.1. South Africa
      • 7.11.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.11.2. Saudi Arabia
      • 7.11.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.11.3. UAE
      • 7.11.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.11.4. Kuwait
      • 7.11.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.11.5. Israel
      • 7.11.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.11.6. Others
      • 7.11.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
    • 8.2.2. Market Leaders
    • 8.2.3. Emerging Players
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2022
  • 8.4. Public Companies
    • 8.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
    • 8.4.2. Company market share/ranking, by region
    • 8.4.3. Competitive dashboard analysis
      • 8.4.3.1. Market differentiators
      • 8.4.3.2. Synergy analysis: major deals and strategic alliances
  • 8.5. Private Companies
    • 8.5.1. List of key emerging company's/technology disruptors/innovators
    • 8.5.2. Funding outlook
    • 8.5.3. Regional network map
    • 8.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
    • 8.5.5. Supplier ranking
    • 8.5.6. Key company profiled
    • 8.5.7. Depomed, Inc.
      • 8.5.7.1. Company overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Product benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. Coating Place, Inc.
      • 8.5.8.1. Company overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Product benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. Corium International, Inc.
      • 8.5.9.1. Company overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Product benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. Johnson and Johnson Services, Inc.
      • 8.5.10.1. Company overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Product benchmarking
      • 8.5.10.4. Strategic Initiative
    • 8.5.11. Alkermes plc
      • 8.5.11.1. Company overview
      • 8.5.11.2. Financial performance
      • 8.5.11.3. Product benchmarking
      • 8.5.11.4. Strategic initiatives
    • 8.5.12. Pfizer, Inc.
      • 8.5.12.1. Company overview
      • 8.5.12.2. Financial performance
      • 8.5.12.3. Product benchmarking
      • 8.5.12.4. Strategic initiatives
    • 8.5.13. Orbis Biosciences, Inc.
      • 8.5.13.1. Company overview
      • 8.5.13.2. Financial performance
      • 8.5.13.3. Product benchmarking
      • 8.5.13.4. Strategic initiatives
    • 8.5.14. Capsugel
      • 8.5.14.1. Company overview
      • 8.5.14.2. Financial performance
      • 8.5.14.3. Product benchmarking
      • 8.5.14.4. Strategic initiatives
    • 8.5.15. Merck and Co., Inc.
      • 8.5.15.1. Company overview
      • 8.5.15.2. Financial performance
      • 8.5.15.3. Product benchmarking
      • 8.5.15.4. Strategic initiatives
    • 8.5.16. Aradigm Corporation
      • 8.5.16.1. Company overview
      • 8.5.16.2. Financial performance
      • 8.5.16.3. Product benchmarking
      • 8.5.16.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America controlled release drug delivery market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 4 North America controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 5 North America controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 6 U.S. controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 7 U.S. controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 8 U.S. controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 9 Canada controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 10 Canada controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 11 Canada controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 12 Europe controlled release drug delivery market, by region, 2018 - 2030 (USD Million)
  • Table 13 Europe controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 14 Europe controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 15 Europe controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 16 Germany controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 17 Germany controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 18 Germany controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 19 U.K. controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 20 U.K. controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 21 U.K. controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 22 France controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 23 France controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 24 France controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 25 Italy controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 26 Italy controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 27 Italy controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 28 Spain controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 29 Spain controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 30 Spain controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 31 The Netherland controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 32 The Netherland controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 33 The Netherland controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 34 Switzerland controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 35 Switzerland controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 36 Switzerland controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 37 Russia controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 38 Russia controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 39 Russia controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 40 Sweden controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 41 Sweden controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 42 Sweden controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 43 Belgium controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 44 Belgium controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 45 Belgium controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific controlled release drug delivery market, by region, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 50 Japan controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 51 Japan controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 52 Japan controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 53 China controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 54 China controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 55 China controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 56 India controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 57 India controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 58 India controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 59 South Korea controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 60 South Korea controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 61 South Korea controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 62 Thailand controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 63 Thailand controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 64 Thailand controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 65 Indonesia controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 66 Indonesia controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 67 Indonesia controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 68 Philippines controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 69 Philippines controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 70 Philippines controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 71 Vietnam controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 72 Vietnam controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 73 Vietnam controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 74 Singapore controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 75 Singapore controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 76 Singapore controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 77 Malaysia controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 78 Malaysia controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 79 Malaysia controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 80 Latin America controlled release drug delivery market, by region, 2018 - 2030 (USD Million)
  • Table 81 Latin America controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 82 Latin America controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 83 Latin America controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 84 Brazil controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 85 Brazil controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 86 Brazil controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 87 Mexico controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 88 Mexico controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 89 Mexico controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 90 Argentina controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 91 Argentina controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 92 Argentina controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 93 Colombia controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 94 Colombia controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 95 Colombia controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 96 Chile controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 97 Chile controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 98 Chile controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 99 Middle east and Africa controlled release drug delivery market, by region, 2018 - 2030 (USD Million)
  • Table 100 Middle east and Africa controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 101 Middle east and Africa controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 102 Middle east and Africa controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 103 South Africa controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 104 South Africa controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 105 South Africa controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 106 Saudi Arabia controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 109 UAE controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 110 UAE controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 111 UAE controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 112 Kuwait controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 113 Kuwait controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 114 Kuwait controlled release drug delivery market, by application, 2018 - 2030 (USD Million)
  • Table 115 Israel controlled release drug delivery market, by technology, 2018 - 2030 (USD Million)
  • Table 116 Israel controlled release drug delivery market, by release mechanism, 2018 - 2030 (USD Million)
  • Table 117 Israel controlled release drug delivery market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 controlled release drug delivery market: market outlook
  • Fig. 14 controlled release drug delivery market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 controlled release drug delivery market driver impact
  • Fig. 20 controlled release drug delivery market restraint impact
  • Fig. 21 controlled release drug delivery market strategic initiatives analysis
  • Fig. 22 controlled release drug delivery market: technology movement analysis
  • Fig. 23 controlled release drug delivery market: technology outlook and key takeaways
  • Fig. 24 Wurster technique market estimates and forecast, 2018 - 2030
  • Fig. 25 Coacervation market estimates and forecast, 2018 - 2030
  • Fig. 26 Micro encapsulation market estimates and forecast, 2018 - 2030
  • Fig. 27 Implants market estimates and forecast, 2018 - 2030
  • Fig. 28 Transdermal market estimates and forecast, 2018 - 2030
  • Fig. 29 Targeted delivery market estimates and forecast, 2018 - 2030
  • Fig. 30 Others market estimates and forecast, 2018 - 2030
  • Fig. 31 controlled release drug delivery market: release mechanism movement analysis
  • Fig. 32 controlled release drug delivery market: release mechanism outlook and key takeaways
  • Fig. 33 Polymer based systems market estimates and forecast, 2018 - 2030
  • Fig. 34 Micro reservoir partition-controlled drug delivery systems estimate and forecasts, 2018 - 2030
  • Fig. 35 Feedback regulate drug delivery systems estimates and forecasts, 2018 - 2030
  • Fig. 36 Activation-modulated drug delivery systems estimates and forecasts, 2018 - 2030
  • Fig. 37 Chemically activated drug delivery systems estimates and forecasts, 2018 - 2030
  • Fig. 38 controlled release drug delivery market: application movement analysis
  • Fig. 39 controlled release drug delivery market: application outlook and key takeaways
  • Fig. 40 Metered dose inhaler market estimates and forecasts, 2018 - 2030
  • Fig. 41 Injectable controlled release drug delivery market estimates and forecasts, 2018 - 2030
  • Fig. 42 Transdermal and Ocular patches controlled release drug delivery market estimates and forecasts, 2018 - 2030
  • Fig. 43 Infusion pumps controlled release drug delivery market estimates and forecasts, 2018 - 2030
  • Fig. 44 Oral controlled drug delivery systems market estimates and forecasts, 2018 - 2030
  • Fig. 45 Drug eluting stents controlled release drug delivery market estimates and forecasts, 2018 - 2030
  • Fig. 46 Global controlled release drug delivery market: regional movement analysis
  • Fig. 47 Global controlled release drug delivery market: regional outlook and key takeaways
  • Fig. 48 Global controlled release drug delivery market shares and leading players
  • Fig. 49 North America market share and leading players
  • Fig. 50 Europe market share and leading players
  • Fig. 51 Asia Pacific market share and leading players
  • Fig. 52 Latin America market share and leading players
  • Fig. 53 Middle East & Africa market share and leading players
  • Fig. 54 North America: SWOT
  • Fig. 55 Europe SWOT
  • Fig. 56 Asia Pacific SWOT
  • Fig. 57 Latin America SWOT
  • Fig. 58 MEA SWOT
  • Fig. 59 North America, by country
  • Fig. 60 North America
  • Fig. 61 North America market estimates and forecasts, 2018 - 2030
  • Fig. 62 U.S.
  • Fig. 63 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 64 Canada
  • Fig. 65 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 66 Europe
  • Fig. 67 Europe. market estimates and forecasts, 2018 - 2030
  • Fig. 68 UK
  • Fig. 69 UK market estimates and forecasts, 2018 - 2030
  • Fig. 70 Germany
  • Fig. 71 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 72 France
  • Fig. 73 France market estimates and forecasts, 2018 - 2030
  • Fig. 74 Italy
  • Fig. 75 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 76 Spain
  • Fig. 77 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 78 Russia
  • Fig. 79 Russia market estimates and forecasts, 2018 - 2030
  • Fig. 80 The Netherlands
  • Fig. 81 The Netherlands market estimates and forecasts, 2018 - 2030
  • Fig. 82 Switzerland
  • Fig. 83 Switzerland market estimates and forecasts, 2018 - 2030
  • Fig. 84 Sweden
  • Fig. 85 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 86 Belgium
  • Fig. 87 Belgium market estimates and forecasts, 2018 - 2030
  • Fig. 88 Asia Pacific
  • Fig. 89 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 90 China
  • Fig. 91 China market estimates and forecasts, 2018 - 2030
  • Fig. 92 Japan
  • Fig. 93 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 94 India
  • Fig. 95 India market estimates and forecasts, 2018 - 2030
  • Fig. 96 Thailand
  • Fig. 97 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 98 South Korea
  • Fig. 99 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 100 Indonesia
  • Fig. 101 Indonesia market estimates and forecasts, 2018 - 2030
  • Fig. 102 Philippines
  • Fig. 103 Taiwan market estimates and forecasts, 2018 - 2030
  • Fig. 104 Vietnam
  • Fig. 105 Singapore market estimates and forecasts, 2018 - 2030
  • Fig. 106 Singapore
  • Fig. 107 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 108 Malaysia
  • Fig. 109 Malaysia market estimates and forecasts, 2018 - 2030
  • Fig. 110 Latin America
  • Fig. 111 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 112 Brazil
  • Fig. 113 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 114 Mexico
  • Fig. 115 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 116 Argentina
  • Fig. 117 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 118 Colombia
  • Fig. 119 Colombia market estimates and forecasts, 2018 - 2030
  • Fig. 120 Chile
  • Fig. 121 Chile market estimates and forecasts, 2018 - 2030
  • Fig. 122 Middle East and Africa
  • Fig. 123 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 124 South Africa
  • Fig. 125 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 126 Saudi Arabia
  • Fig. 127 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 128 UAE
  • Fig. 129 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 130 Kuwait
  • Fig. 131 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 132 Israel
  • Fig. 133 Israel market estimates and forecasts, 2018 - 2030
  • Fig. 134 Participant categorization- controlled release drug delivery market
  • Fig. 135 Market share of key market players- controlled release drug delivery market